[1]卢丽琴,付晓红,宋慧东.GClnc1通过SIRT3/FOXO3/SOD2信号通路促进胃癌细胞SGC7901的增殖和迁移[J].第三军医大学学报,2019,41(07):673-677.
 LU Liqin,FU Xiaohong,SONG Huidong.GClnc1 promotes proliferation and migration of human gastric cancer cells in vitro by activating SIRT3/FOXO3/SOD2 pathway[J].J Third Mil Med Univ,2019,41(07):673-677.
点击复制

GClnc1通过SIRT3/FOXO3/SOD2信号通路促进胃癌细胞SGC7901的增殖和迁移(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第07期
页码:
673-677
栏目:
基础医学
出版日期:
2019-04-15

文章信息/Info

Title:
GClnc1 promotes proliferation and migration of human gastric cancer cells in vitro by activating SIRT3/FOXO3/SOD2 pathway
作者:
卢丽琴付晓红 宋慧东
广州市第十二人民医院消化内科;深圳市南山区人民医院肿瘤科
Author(s):
LU Liqin FU Xiaohong SONG Huidong  

Department of Gastroenterology,Guangzhou No.12 People’s Hospital,Guangzhou,Guangdong Province,510000; Department of Oncology, the People’s Hospital of Nanshan District, Shenzhen, Guangdong Province,518000,China

 

关键词:
GClnc1胃癌SITR3FOXO3SOD2  
Keywords:
GClnc1 gastric cancer SITR3 FOXO3 SOD2
分类号:
R394.2; R730.23; R735.2
文献标志码:
A
摘要:

目的 探究lncRNA GClnc1是否通过SIRT3/FOXO3/SOD2调控胃癌细胞增殖和迁移。方法 通过转染慢病毒的方法,在人胃癌细胞SGC7901中分别过表达和沉默GClnc1,采用Western blot和qRTPCR检测SIRT3/FOXO3/SOD2 mRNA和蛋白水平的改变;在过表达GClnc1的同时分别沉默SIRT3/FOXO3/SOD2,采用CCK8检测细胞增殖能力,划痕实验检测细胞迁移能力。结果 过表达GClnc1可以上调SIRT3/FOXO3/SOD2的mRNA和蛋白水平(P<0.05),并增强SGC7901细胞的增殖[(1.00±0.14 ) vs (1.79±0.21), P<0.05]和迁移能力(10.87±0.76 vs 16.53±2.25, P<0.05),而沉默GClnc1则降低SIRT3/FOXO3/SOD2的mRNA和蛋白水平(P<0.05),并减少细胞增殖(1.00±0.14 vs 0.62±0.13, P<0.05)和迁移能力(10.87±0.76 vs 6.46±0.89, P<0.01)。沉默SIRT3/FOXO3/SOD2可以消除过表达GClnc1对细胞增殖和迁移能力的促进作用。结论 GClnc1通过激活SIRT3/FOXO3/SOD2信号通路促进SGC7901细胞增殖和迁移。

 

Abstract:

Objective To investigate whether the long noncoding RNA (lncRNA) GClnc1 regulates the proliferation and migration of gastric cancer cells by modulating the expression of SIRT3/FOXO3/SOD2 pathway. Methods We transfected human gastric cancer SGC7901 cells with lentiviral vectors to induce overexpression or knockdown of GClnc1, and examined the changes in the expression of SIRT3/FOXO3/SOD2 at both mRNA and protein levels using qRT-PCR and Western blotting. We also observed the effects of SIRT3/FOXO3/SOD2 silencing on the proliferation and migration of GClnc1-overexpressing SGC7901 cells using CCK8 assay and scratch wound healing assay, respectively. Results Overexpression of GClnc1 significantly up-regulated the mRNA and protein levels of SIRT3/FOXO3/SOD2 (P<0.05), and obviously enhanced the proliferation and migration of SGC7901 cells (P<0.05). GClnc1 knockdown significantly lowered the the mRNA and protein levels of SIRT3/FOXO3/SOD2 (P<0.05) and inhibited the proliferation and migration of the cells (P<0.05). Silencing SIRT3/FOXO3/SOD2 obviously eliminated the effect of GClnc1 overexpression on the cell proliferation and migration. Conclusion GClnc1 promotes proliferation and migration of SGC7901 cells by activating SIRT3/FOXO3/SOD2 pathway

参考文献/References:

[1]SUN T T, DU W, XIONG H, et al. TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcome[J]. Clin Cancer Res, 2014, 20(17): 4689-4704. DOI: 10.1158/1078-0432.CCR-14-0315.
[2]左婷婷, 郑荣寿, 曾红梅, 等. 中国胃癌流行病学现状[J]. 中国肿瘤临床, 2017, 44(1): 52-58. DOI: 10.3969/j.issn.1000-8179.2017.01.881.
ZUO T T, ZHENG R S, ZENG H M, et al. Epidemiology of stomach cancer in China[J]. Chin Clin Oncol, 2017, 44(1): 52-58. DOI: 10.3969/j.issn.1000-8179.2017.01.881.
[3]COHEN J D, LI L, WANG Y X, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test[J]. Science, 2018, 359(6378): 926-930. DOI: 10.1126/science.aar3247.
[4]SUN T T, HE J, LIANG Q, et al. LncRNA GClnc1 promotes gastric carcinogenesis and may act as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern[J]. Cancer Discov, 2016, 6(7): 784-801. DOI: 10.1158/2159-8290.CD-15-0921.
[5]KENNY T C, HART P, RAGAZZI M, et al. Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis[J]. Oncogene, 2017, 36(31): 4393-4404. DOI: 10.1038/onc.2017.52.
[6]SCHMITT A M, CHANG H Y. Long noncoding RNAs in cancer pathways[J]. Cancer Cell, 2016, 29(4): 452-463. DOI: 10.1016/j.ccell.2016.03.010.
[7]YANG G D, LU X Z, YUAN L J. LncRNA: a link between RNA and cancer[J]. Biochim Biophys Acta, 2014, 1839(11): 1097-1109. DOI: 10.1016/j.bbagrm.2014.08.012.
[8]CHEN Y, FU L L, WEN X, et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer[J]. Cell Death Dis, 2014, 5: e1047. DOI: 10.1038/cddis.2014.14.
[9]SUNDARESAN N R, SAMANT S A, PILLAI V B, et al. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70[J]. Mol Cell Biol, 2008, 28(20): 6384-6401. DOI: 10.1128/MCB.00426-08.
[10]ALHAZZAZI T Y, KAMARAJAN P, JOO N, et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer[J]. Cancer, 2011, 117(8): 1670-1678. DOI: 10.1002/cncr.25676.
[11]WEBB A E, BRUNET A. FOXO transcription factors: key regulators of cellular quality control[J]. Trends Biochem Sci, 2014, 39(4): 159-169. DOI: 10.1016/j.tibs.2014.02.003.
[12]COOMANS DE BRACHNE A, DEMOULIN J B. FOXO transcription factors in cancer development and therapy[J]. Cell Mol Life Sci, 2016, 73(6): 1159-1172. DOI: 10.1007/s000180152112y.
[13]KIM Y S, GUPTA VALLUR P, PHA TON R, et al. Insights into the dichotomous regulation of SOD2 in cancer[J]. Antioxidants (Basel), 2017, 6(4): E86. DOI: 10.3390/antiox6040086.
[14]LIU Z H, HE Q T, DING X Q, et al. SOD2 is a Cmyc target gene that promotes the migration and invasion of tongue squamous cell carcinoma involving cancer stemlike cells[J]. Int J Biochem Cell Biol, 2015, 60: 139-146. DOI: 10.1016/j.biocel.2014.12.022.
[15]HU J, HWANG S S, LIESA M, et al. Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer[J]. Cell, 2012, 148(4): 651-663. DOI: 10.1016/j.cell.2011.12.028.
[16]LIU X H, ZHANG L, WANG P, et al. Sirt3-dependent deacetylation of SOD2 plays a protective role against oxidative stress in oocytes from diabetic mice[J]. Cell Cycle, 2017, 16(13): 1302-1308. DOI: 10.1080/15384101.2017.1320004.
 

相似文献/References:

[1]杨兆瑞,吴晴,陈嘉薇,等.HIF-1α、JNK1、P-gp、MRP1和LRP蛋白在胃癌中的表达与临床病理及预后的关系[J].第三军医大学学报,2007,29(18):1755.
 YANG Zhao-rui,WU Qing,CHEN Jia-wei,et al.Expressions, clinicopathological features and prognostic significance of HIF-1α, JNK1, P-gp, MRP1 and LRP proteins in human gastric carcinoma[J].J Third Mil Med Univ,2007,29(07):1755.
[2]李勇,范立侨,赵群,等.针对survivin的反义寡核苷酸对人胃癌细胞株BGC-823生长、侵袭、迁移能力的影响[J].第三军医大学学报,2011,33(13):1350.
 Li Yong,Fan Liqiao,Zhao Qun,et al.Anti-survivin oligonucleotides suppresses growth, invasion and migration in human gastric cancer BGC-823 cells[J].J Third Mil Med Univ,2011,33(07):1350.
[3]马华,梅峰,马千里,等.Reg Ⅳ在胃癌中的表达及其临床意义[J].第三军医大学学报,2006,28(05):441.
[4]孙永强,王强,郑国静,等.罗非昔布对裸鼠人胃癌原位种植瘤组织中血管内皮生长因子和诱导型一氧化氮合酶表达的影响[J].第三军医大学学报,2007,29(10):929.
 SUN Yong-qiang,WANG Qiang,ZHENG Guo-jing,et al.Effect of rofecoxib on expressions of VEGF and inducible NOS in human gastric carcinoma tissues established in nude mice by orthotopic transplantation[J].J Third Mil Med Univ,2007,29(07):929.
[5]俞慧宏,吴小翎,张苜,等.测定胃癌患者肿瘤组织与外周血中前列腺素E2的临床意义[J].第三军医大学学报,2008,30(05):444.
 YU Hui-hong,WU Xiao-ling,ZHANG Mu,et al.Prostaglandin E2 in peripheral blood and tumor mass of patients with gastric cancer[J].J Third Mil Med Univ,2008,30(07):444.
[6]孙梯业,赵永亮,颜伟,等.CXCR4在VEGF-C介导的胃癌淋巴道转移中的作用[J].第三军医大学学报,2008,30(02):161.
 SUN Ti-ye,ZHAO Yong-liang,YAN Wei,et al.Role of CXCR4 in lymph node metastasis promoted by VEGF-C in gastric carcinoma[J].J Third Mil Med Univ,2008,30(07):161.
[7]肖天英,李琦.以下肢静脉血栓、乳糜腹、双侧胸腔积液及肺栓塞为主要表现的胃癌1例[J].第三军医大学学报,2007,29(18):1741.
[8]郭红,郝嘉,吴超,等.hTERT隐性表位肽核酸病毒样颗粒疫苗抗胃癌免疫的初步研究[J].第三军医大学学报,2006,28(02):169.
[9]余佩武.腹腔镜胃癌根治术的应用现状与展望[J].第三军医大学学报,2008,30(19):1775.
[10]张坤,余佩武,高朋芬,等.胃癌细胞-树突状细胞融合疫苗肿瘤细胞杀伤活性研究[J].第三军医大学学报,2006,28(05):404.

更新日期/Last Update: 2019-04-05